share_log

Top 3 Health Care Stocks That Are Set To Fly This Quarter

Top 3 Health Care Stocks That Are Set To Fly This Quarter

前三家醫療保健股票在本季度有望上漲
Benzinga ·  08/01 09:16

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

醫療保健領域超賣次數最多的股票爲買入被低估的公司提供了機會。

The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro.

RSI是一個動量指標,它比較股票在價格上漲的日子裏的走強與價格下跌的日子的走強。與股票的價格走勢相比,它可以讓交易者更好地了解股票在短期內的表現。根據Benzinga Pro的數據,當相對強弱指數低於30時,資產通常被視爲超賣。

Here's the latest list of major oversold players in this sector, having an RSI near or below 30.

以下是該行業主要超賣參與者的最新名單,RSI接近或低於30。

BIMI Holdings Inc (NASDAQ:BIMI)

BIMI Holdings Inc(納斯達克股票代碼:BIMI)

  • On May 20, BIMI announced the receipt of a delinquency compliance alert notice from Nasdaq. The company's stock fell around 68% over the past five days and has a 52-week low of $0.24.
  • RSI Value: 24.62
  • BIMI Price Action: Shares of BIMI Holdings closed at $0.42 on Wednesday.
  • Benzinga Pro's charting tool helped identify the trend in DXCM stock.
  • 5月20日,BIMI宣佈收到納斯達克的違法合規警報通知。該公司的股票在過去五天中下跌了約68%,跌至52周低點0.24美元。
  • RSI 值:24.62
  • BIMI價格走勢:BIMI控股的股價週三收於0.42美元。
  • Benzinga Pro的圖表工具幫助確定了DxCM股票的走勢。

Edwards Lifesciences Corp (NYSE:EW)

愛德華茲生命科學公司(紐約證券交易所代碼:EW)

  • On July 24, Edwards Lifesciences reported worse-than-expected second-quarter sales results and issued third-quarter guidance below estimates. Also, the company acquired JenaValve and Endotronix.. The company's stock fell around 30% over the past month. It has a 52-week low of $58.93.
  • RSI Value: 22.55
  • EW Price Action: Shares of Edwards Lifesciences closed at $63.05 on Wednesday.
  • Benzinga Pro's real-time newsfeed alerted to latest EW news.
  • 7月24日,愛德華茲生命科學公佈的第二季度銷售業績低於預期,併發布的第三季度指引低於預期。此外,該公司還收購了JenaValve和Endotronix。該公司的股票在過去一個月中下跌了約30%。它的52周低點爲58.93美元。
  • RSI 值:22.55
  • EW價格走勢:愛德華茲生命科學的股價週三收於63.05美元。
  • Benzinga Pro 的實時新聞提醒注意最新的 EW 新聞。

Merck & Co Inc (NYSE:MRK)

默沙東公司(紐約證券交易所代碼:MRK)

  • Merck reported better-than-expected second-quarter earnings and sales results on Tuesday. The company posted quarterly sales of $16.1 billion, up 7% year-over-year, beating the consensus estimate of $15.84 billion. Excluding the impact of foreign exchange, sales increased 11%. Merck reported adjusted EPS of $2.28, a shift from an EPS loss of $(2.06), beating the consensus of $2.15. The company's shares fell around 12% over the past month and has a 52-week low of $99.14.
  • RSI Value: 28.20
  • MRK Price Action: Shares of Merck rose 0.1% to close at $113.13 on Wednesday.
  • 默沙東周二公佈的第二季度收益和銷售業績好於預期。該公司公佈的季度銷售額爲161億美元,同比增長7%,超過了市場普遍預期的158.4億美元。不包括外匯的影響,銷售額增長了11%。默沙東報告調整後的每股收益爲2.28美元,較每股收益虧損2.06美元(2.06美元)有所變化,超過了市場普遍的2.15美元。該公司的股價在過去一個月中下跌了約12%,跌至52周低點99.14美元。
  • RSI 值:28.20
  • MrK價格走勢:週三,默沙東股價上漲0.1%,收於113.13美元。

Read More:

閱讀更多:

  • Nasdaq Settles Higher As Nvidia Records Best Session Since February: Fear & Greed Index Now In 'Neutral' Zone As Investor Sentiment Improves
  • 由於英偉達創下2月以來的最佳交易日,納斯達克指數收高:隨着投資者情緒的改善,恐懼與貪婪指數現處於 “中性” 區域
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論